1.A clinical study about the maxillectomized patients and obturators by maxillary cancer.
Yong Kack KIM ; Hyung Kook PARK
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1997;23(1):69-77
During 10 years (from 1986 to 1995), 54 patients were diagnosed as maxillary cancer and undergone maxillectomy in department of Oral and Maxillofacial Surgery, Korea Cancer Center Hospital. We studied clinically about their age and sex distribution, TNM staging, histopathologic diagnoses, treatment modalities, overall survival rates, survival rates according to stages and treatment modalities. In them, 23 patients were delivered maxillary obturators, we also studied clinically about them and their obturators. The overall 3-year and 5-year survival rates of these maxillectomized patients were 59.0% and 55.0%. The 5-year survival rates of stage II and stage III patients was 63.0%, and that of stage IV patient was 50.0%. According to treatment modalities, The 5-year survival rates in cases of surgery only was 66.7%, in cases of preoperative chemotherapy and/or radiaiotherapy was 63.5%, in cases of postoperative radiotherapy and/or chemotherapy was 50.4%. The 5-year survival rate of obturator delivered patients was 56.8%, and that of no-obturator delivered patients was 51.8%. The using rates of obturator were 70.5% at 1 year, 59.7% at 2 years, and 53.0% at 3 years.
Diagnosis
;
Drug Therapy
;
Humans
;
Korea
;
Neoplasm Staging
;
Radiotherapy
;
Sex Distribution
;
Surgery, Oral
;
Survival Rate
2.Making In Vivo Model To Study About Human Oral Cancer (I)
Hyung Kook PARK ; Yong Kack KIM
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 1997;19(3):300-310
Animals
;
Cell Line
;
Housing
;
Humans
;
Mice
;
Mice, Nude
;
Mouth Neoplasms
;
Neoplasms, Squamous Cell
4.A clinical study of the osteoradionecrosis of the jaw.
Yong Kack KIM ; Heon Seok YU ; Jae Keun KWAK ; Kyu Yeong KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1993;19(2):177-184
No abstract available.
Jaw*
;
Osteoradionecrosis*
5.A clinical study of the osteoradionecrosis of the jaw.
Yong Kack KIM ; Heon Seok YU ; Jae Keun KWAK ; Kyu Yeong KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1993;19(2):177-184
No abstract available.
Jaw*
;
Osteoradionecrosis*
8.Clinical Study of Positron Emission Tomography with 18F-Fluorodeoxyglucose in Maxillofacial Tumor Diagnosis.
Jae Hwan KIM ; Kyung Wook KIM ; Yong Kack KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2000;26(5):462-469
Positron Emission Tomography(PET) is a new diagnostic method that can create functional images of the distribution of positron emitting radionuclides, which when administered intravenously in the body, makes possible anatomical and functional analysis by quantity of biochemical and physiological process. After genetic and biochemical changes in initial stage, malignant tumor undergoes functional changes before undergoing anatomical changes. So, early diagnosis of malignant tumors by functional analysis with PET can be achieved, replacing traditional anatomical analysis, such as computed tomography(CT) and magnetic resonance image(MRI), etc. Similarly, PET can identify malignant tumor without confusion with scar and fibrosis in follow up check. In the Korea Cancer Center Hospital(KCCH) from October 1997 to September 1999, clinical study was performed in 79 cases that underwent 89 times PET evaluation with [18F]-Fluorodeoxyglucose for diagnosis of oral and maxillofacial tumors, and the data was analysed by Bayesian 2x2 Classification Table. The results were as follows : Evaluation for initial diagnosis with FDG-PET (P<0.005) 1. Agreement rate or accuracy rate is 88.9%. 2. Sensitivity is 95.2%, and specificity 66.7%. 3. Positive predictive rate is 90.9%, and negative predictive rate 80.0%. 4. In consideration of tumor stage, diagnostic rate in less than stage II was 90% and in greater than stage III 100%. 5. In consideration of tumor size, diagnostic rate in less than T2 was 92.3% and in greater than T3 100%. After primary treatment, evaluation for follow up check with FDG-PET (P < 0.001) 1. Agreement rate or accuracy rate is 85.4%. 2. Sensitivity is 87.5%, and specificity 82.4%. 3. Positive predictive rate is 87.5%, and negative predictive rate 82.4%. 4. In 24 recurred cases, 6 had distant metastasis, and 5 of them were diagnosed with FDG-PET, resulting in diagnostic rate of FDG-PET of 83.3%. From the above results, Positron Emission Tomography with [18F]- Fluorodeoxyglucose appears to be more sensitive and accurate for detecting the presence of oral and maxillofacial tumors, and has various clinical applications such as early diagnosis of tumor in initial and follow up check and detection of distant metastasis.
Cicatrix
;
Classification
;
Diagnosis*
;
Early Diagnosis
;
Electrons*
;
Fibrosis
;
Follow-Up Studies
;
Korea
;
Neoplasm Metastasis
;
Physiological Processes
;
Positron-Emission Tomography*
;
Radioisotopes
;
Sensitivity and Specificity
9.The PET/CT in the diagnosis of oral cancer: clinical cases.
Sung Jin KIM ; Yong Kack KIM ; Chul KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2005;31(2):178-182
With the development of systemic diagnostic technique in cancer, the diagnostic methods of head and neck region are developing, also. Now, it is usually used computed tomography(CT), magnetic resornance image(MRI) in head and neck cancer and positron emission tomography(PET) is being increased in diagnostic use because of tumor specificity and accuracy. However, CT and MRI show the advantage of showing precise anatomical landmarks, but the disadvantage of these methods is much affecting by anatomical variations and changes. Otherwise, PET presents the imaging of physiologic and biochemical phenomenon and the disadvantage is the difficult differentiation of normal physiologic uptake, the lack of normal anatomical landmarks. PET/CT, the combination of clinical PET and CT imaging in a single unit is introduced recently, and it helps to get more accurate diagnostic interpretation and to improve in evaluating response to therapy, in management of patients with malignant tumors. So, we report the advantages of PET/CT in the diagnosis of oral cancer with review of literatures.
Biochemical Phenomena
;
Diagnosis*
;
Electrons
;
Head
;
Head and Neck Neoplasms
;
Humans
;
Magnetic Resonance Imaging
;
Mouth Neoplasms*
;
Neck
;
Positron-Emission Tomography and Computed Tomography*
;
Sensitivity and Specificity